CytoDyn Inc. (CYDY)
CytoDyn, Inc. is a clinical-stage biotechnology company, which focuses on the clinical development of innovative treatments for multiple therapeutic indications based on its product candidate, leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5. Its pipeline includes Leronlimab Clinical Development Pipeline and Long-Acting CCR5 Inhibitor Development Pipeline. The company was founded by Allen D. Allen on May 2, 2002 and is headquartered in Vancouver, WA.
Address
1111 MAIN STREET, SUITE 660
VANCOUVER, WA 98660
Founded
2002
Number of Employees
9
Website
http://www.cytodyn.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)